Fidelity Investments’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Fidelity Investments’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-53	Closed	-$3K	–	5647
2022 Q2	$3K	Sell	53 -51,947	-100%	-$2.73M	﹤0.01%	4523
2022 Q1	$1.67M	Buy	+52,000	New	+$1.49M	﹤0.01%	2661
2018 Q2	–	Sell	-4,273	Closed	-$354K	–	2746
2018 Q1	$354K	Hold	4,273	–	–	﹤0.01%	2555
2017 Q4	$637K	Hold	4,273	–	–	﹤0.01%	2495
2017 Q3	$265K	Hold	4,273	–	–	﹤0.01%	2543
2017 Q2	$200K	Sell	4,273 -655	-13%	-$33.4K	﹤0.01%	2592
2017 Q1	$302K	Hold	4,928	–	–	﹤0.01%	2582
2016 Q4	$294K	Hold	4,928	–	–	﹤0.01%	2586
2016 Q3	$359K	Hold	4,928	–	–	﹤0.01%	2572
2016 Q2	$392K	Sell	4,928 -105,265	-96%	-$20.1M	﹤0.01%	2574
2016 Q1	$29.7M	Sell	110,193 -2,525	-2%	-$806K	﹤0.01%	1480
2015 Q4	$67.8M	Hold	112,718	–	–	0.01%	1136
2015 Q3	$92.5M	Buy	+112,718	New	+$127M	0.01%	985

Other funds holding SRRA

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Fidelity Investments's SRRA Position: Q3 2022 in Review

Fidelity Investments sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 53 shares — an estimated $3K sold.

Fidelity Investments first reported a position in SRRA in Q3 2015 and held it in 13 quarters. The position peaked at $92.5M in Q3 2015. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

Fidelity Investments reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Fidelity Investments sold 53 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $3K.
Fidelity Investments first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2015 and held it in 13 quarters.
Fidelity Investments's Sierra Oncology, Inc. Common Stock position peaked at $92.5M in Q3 2015.
1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Fidelity Investments's 13F filing for Q3 2022, filed 10 Nov 2022.